SThree Share News (STEM)

SThree net fees grow in first quarter, in line with expectations

(Alliance News) - SThree PLC on Tuesday said net fees grew in the first quarter of its financial year, in line with its expectations.

LONDON BROKER RATINGS: SocGen cuts Ferguson to 'hold' from 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Shaftesbury and Capital & Counties merger scheme implemented

(Alliance News) - Shaftesbury PLC on Thursday announced the scheme for its all-share merger with Capital & Counties Properties PLC is being implemented.

SThree to replace Shaftesbury in the FTSE 250 following merger

(Alliance News) - FTSE Russell said on Wednesday that SThree PLC will be added to the FTSE 250 index, replacing Shaftesbury PLC which is being removed.

TOP NEWS: No FTSE 100 promotions but Moonpig, 888 tipped to leave 250s

(Alliance News) - No mid-cap stock will break into London's FTSE 100 blue-chip benchmark at the next index review, according to indicative changes provided by FTSE Russell on Tuesday.

SThree posts jump in full-year profits, hikes dividend payout by nearly half

(Sharecast News) - SThree posted a sharp jump in full-year and hiked its final dividend by nearly two-fifths.

UK earnings, trading statements calendar - next 7 days

LONDON MARKET MIDDAY: FTSE 100 pares loss before Powell takes stage

(Alliance News) - Stock prices in London fell short of producing a mid-morning turnaround but did go into Tuesday afternoon off session lows, though US interest rate worries still cast a dark cloud.

SThree posts annual net fees rise with growth boosted by technology

(Alliance News) - SThree PLC on Wednesday reported higher net fee income across all its regions for the financial year ended November 30.

SMALL-CAP WINNERS & LOSERS: Dalata expects record-breaking revenue

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

Oxford Biomedica strikes new AAV agreements with US firms

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has struck agreements with three US biotechnology companies, bringing the firm's total number of new adeno-associated virus customers in 2022 to four.

SThree delivers 'record' FY performance

(Sharecast News) - Staffing firm SThree said on Wednesday that it had delivered a "record performance" for the year ended 30 November, with double-digit growth across all regions.

UK earnings, trading statements calendar - next 7 days

LONDON BROKER RATINGS: Jefferies cuts PageGroup but keeps Hays at buy

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon:

Jefferies downgrades PageGroup to 'underperform'

(Sharecast News) - Jefferies downgraded its stance on PageGroup on Wednesday as it took a look at European recruiters.